Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00732173 · ClinicalTrials.gov registry record · NA

Exercise and Healthy Diet or Standard Care in Patients in Remission From Stage I or Stage II Endometrial Cancer

A NA study, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
74
Enrollment target

NCT00732173: Completed NA study, sponsored by Case Comprehensive Cancer Center.

NCT00732173 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00732173, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
74 participants
Enrollment target

Study Summary

RATIONALE: Participating in a diet and exercise program may improve the quality of life of overweight and obese patients who are in remission from endometrial cancer. PURPOSE: This randomized phase I trial is studying an exercise and healthy diet program to see how well it works compared with standard care in patients in remission from stage I or stage II endometrial cancer.

Primary Outcome

Analysis will be carried out by fitting a mixed model. Weight change will be expressed in terms of absolute and relative weight change. In addition, percent weight change will be calculated. To test the null hypotheses that the groups do not differ in terms of change in weight at 6 or 12 months, parameter estimates from the model will be used to construct subsequent t-test that the difference in means at 3, 6, or 12 months is zero.

Interventions

  • OTHER survey administration
  • BEHAVIORAL exercise intervention
  • OTHER educational intervention
  • OTHER counseling intervention
  • BEHAVIORAL behavioral dietary intervention

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2008-07
Est. Completion 2011-03
Phase NA
Case Comprehensive Cancer Center

407 total trials

What the finished NCT00732173 record still lists

NCT00732173 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 5 interventions - of which survey administration is the first listed.

NCT00732173 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00732173 about?

NCT00732173 is a clinical study titled "Exercise and Healthy Diet or Standard Care in Patients in Remission From Stage I or Stage II Endometrial Cancer". RATIONALE: Participating in a diet and exercise program may improve the quality of life of overweight and obese patients who are in remission from endometrial cancer. PURPOSE: This randomized phase I trial is studying an exercise and healthy diet program to see how well it works compared with stand...

What is the current status of trial NCT00732173?

This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2008-07. Estimated completion is 2011-03.

What interventions are being tested in trial NCT00732173?

The interventions under investigation include: survey administration (OTHER), exercise intervention (BEHAVIORAL), educational intervention (OTHER), counseling intervention (OTHER), behavioral dietary intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00732173?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00732173's enrollment target sits among peer trials

74 1082nd of 2000 higher than 912 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT04771156 · 74 participants · Phase 4

    Ketorolac in Palatoplasty

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00732173, the US trial registry maintained by the National Library of Medicine. NCT00732173 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.